167 related articles for article (PubMed ID: 38402159)
1. Cytosolic Cadherin 4 promotes angiogenesis and metastasis in papillary thyroid cancer by suppressing the ubiquitination/degradation of β-catenin.
Wu L; Xiao J; Yi D; Ding H; Wang R; Duan Z; Liu Z; Shi X; Shen M; Sang J
J Transl Med; 2024 Feb; 22(1):201. PubMed ID: 38402159
[TBL] [Abstract][Full Text] [Related]
2. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway.
Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J
J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
4. Novel LncRNA AK023507 inhibits cell metastasis and proliferation in Papillary Thyroid Cancer through β-catenin/Wnt Signaling Pathway.
Yang M; Huang S; Zhao Y; Xie B; Hu X; Cai Y
Biochem Biophys Res Commun; 2023 May; 655():104-109. PubMed ID: 36934585
[TBL] [Abstract][Full Text] [Related]
5. Dickkopf-1 inhibits thyroid cancer cell survival and migration through regulation of β-catenin/E-cadherin signaling.
Cho SW; Lee EJ; Kim H; Kim SH; Ahn HY; Kim YA; Yi KH; Park DJ; Shin CS; Ahn SH; Cho BY; Park YJ
Mol Cell Endocrinol; 2013 Feb; 366(1):90-8. PubMed ID: 23261982
[TBL] [Abstract][Full Text] [Related]
6. LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling.
Wang X; Lu X; Geng Z; Yang G; Shi Y
J Cell Biochem; 2017 Dec; 118(12):4745-4752. PubMed ID: 28513866
[TBL] [Abstract][Full Text] [Related]
7. SDC4 Gene Silencing Favors Human Papillary Thyroid Carcinoma Cell Apoptosis and Inhibits Epithelial Mesenchymal Transition
Chen LL; Gao GX; Shen FX; Chen X; Gong XH; Wu WJ
Mol Cells; 2018 Sep; 41(9):853-867. PubMed ID: 30165731
[TBL] [Abstract][Full Text] [Related]
8. TRIM30 modulates Interleukin-22-regulated papillary thyroid Cancer cell migration and invasion by targeting Sox17 for K48-linked Polyubiquitination.
Li W; Li F; Lei W; Tao Z
Cell Commun Signal; 2019 Dec; 17(1):162. PubMed ID: 31823782
[TBL] [Abstract][Full Text] [Related]
9. LncRNA FALEC promotes proliferation, migration, and invasion of PTC cells through regulating Wnt/β-catenin signaling pathway.
Xiao X; Li L; Cui JC; Wang Y
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4361-4367. PubMed ID: 32373973
[TBL] [Abstract][Full Text] [Related]
10. LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.
Michelotti G; Jiang X; Sosa JA; Diehl AM; Henderson BB
Oncotarget; 2015 Oct; 6(33):34549-60. PubMed ID: 26416247
[TBL] [Abstract][Full Text] [Related]
11. ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating Axin2 through Wnt/β-catenin signaling pathway.
Lv P; Xue Y
Bioengineered; 2021 Dec; 12(1):3873-3885. PubMed ID: 34281460
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of Dickkopf-1 in wild-type BRAF papillary thyroid cancer via regulation of β-catenin/E-cadherin signaling.
Cho SW; Kim YA; Sun HJ; Ahn HY; Lee EK; Yi KH; Oh BC; Park DJ; Cho BY; Park YJ
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1641-9. PubMed ID: 24848709
[TBL] [Abstract][Full Text] [Related]
13. KCNIP3 silence promotes proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma through activating Wnt/β-catenin pathway.
Zhong J; Lin R; Wang G; Lin L; Ruan S; Liu W
Tissue Cell; 2022 Apr; 75():101739. PubMed ID: 35066335
[TBL] [Abstract][Full Text] [Related]
14. FOXN3 suppresses the growth and invasion of papillary thyroid cancer through the inactivation of Wnt/β-catenin pathway.
Zhao C; Mo L; Li C; Han S; Zhao W; Liu L
Mol Cell Endocrinol; 2020 Sep; 515():110925. PubMed ID: 32619584
[TBL] [Abstract][Full Text] [Related]
15. Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of β-catenin pathway.
Cui D; Zhao Y; Xu J
Biochimie; 2018 May; 148():1-11. PubMed ID: 29471001
[TBL] [Abstract][Full Text] [Related]
16. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling.
Zhang X; Li M; Zuo K; Li D; Ye M; Ding L; Cai H; Fu D; Fan Y; Lv Z
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1305-13. PubMed ID: 23796566
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.
Zhou Z; Liu Y; Ma M; Chang L
Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013
[TBL] [Abstract][Full Text] [Related]
18. CDK5RAP3 acts as a putative tumor inhibitor in papillary thyroid carcinoma via modulation of Akt/GSK-3β/Wnt/β-catenin signaling.
Feng X; Jiang J; Sun L; Zhou Q
Toxicol Appl Pharmacol; 2022 Apr; 440():115940. PubMed ID: 35219640
[TBL] [Abstract][Full Text] [Related]
19. ANKRD22 knockdown suppresses papillary thyroid cell carcinoma growth and migration and modulates the Wnt/β-catenin signaling pathway.
Wu Y; Chen W; Zhang B; Liu H
Tissue Cell; 2023 Oct; 84():102193. PubMed ID: 37586180
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of cell-adhesion molecules in histological variants of papillary thyroid carcinoma.
Andriescu EC; Căruntu ID; Giuşcă SE; Lozneanu L; Ciobanu Apostol DG
Rom J Morphol Embryol; 2018; 59(3):721-727. PubMed ID: 30534810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]